| Literature DB >> 16880078 |
Maria Laura Bertolaccini1, Graham R V Hughes.
Abstract
Laboratory diagnosis of APS relies on the demonstration of a positive test for aPL. In clinical practice, the gold standard tests are those that detect beta2GPI-dependent aCL or LA. The question on the use of anti-beta2GPI asa routine diagnostic test remains unanswered, and testing for these antibodies should be only performed in very selected cases and not as an alternative to aCL or LA testing. Clinical utility and standardization are still lacking for other aPL specificities; therefore, their application as routine diagnostic tools is not recommended.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16880078 DOI: 10.1016/j.rdc.2006.05.001
Source DB: PubMed Journal: Rheum Dis Clin North Am ISSN: 0889-857X Impact factor: 2.670